Discover Valsynthese’s tailored chemical solutions for the personal care industry, designed to turn complex ideas into high‑quality ingredients.
Discover Valsynthese’s tailored chemical solutions for the personal care industry, designed to turn complex ideas into high‑quality ingredients.
Selected dianhydrides are converted into tailored imide derivatives for advanced polymer systems. Discover our products for high-performance and specialty materials.
Material Information Sheet
Bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic 2,3:5,6-diimide (BTI)
Material Information Sheet
Bicyclo[2.2.2]oct-7-ene-2,3:5,6-tetracarboxylic dianhydride (BTA)
Material Information Sheet
1,2,4,5-Cyclohexanetetracarboxylic 1,2:4,5-dianhydride (CHDA)
Material Information Sheet
1,2,4,5-Cyclohexanetetracarboxylic 1,2:4,5-diimide (CHDI)
Material Information Sheet
1,2,3,4,5,6-Cyclohexanehexacarboxylic 1,2:3,4:5,6-trianhydride (CHHA)
Material Information Sheet
Bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic 2,3:5,6-dianhydride (HBTA)
Material Information Sheet
Bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic 2,3:5,6-diimide (HBTI)
Material Information Sheet
N,N’-Bis(4-hydroxyphenyl)bicyclo[2,2,2]oct-7-ene-2,3,5,6-tetracarboxylic 2:3,5:6-diimide (BTA-PAP)
Material Information Sheet
N,N’-Bis(2-hydroxyethyl)bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic 2:3,5:6-diimide (BODI)
New Catalogue product
APMN, 4-(4’-aminophenyl)-morpholin-3-one, the key intermediate for Rivaroxaban (2.5 mg), a worldwide produced blood thinner, is now part of our catalogue product portfolio. Valsynthese SA has recently launched a strategic investment in hydrogenation, of which APMN is one of the key products.
New Catalogue product
HBTA, Bicyclooctanetetracarboxylic dianhydride, a very promising key intermediate for electronic chemistry, is now part of our catalogue product portfolio. Valsynthese SA has recently launched a strategic investment in hydrogenation. HBTA is one of the key products.
